Drug repositioning candidates identified using in-silico quasi-quantum molecular simulation demonstrate reduced COVID-19 mortality in 1.5M patient records

BACKGROUND: Drug repositioning is a key component of COVID-19 pandemic response, through identification of existing drugs that can effectively disrupt COVID-19 disease processes, contributing valuable insights into disease pathways. Traditional non in silico drug repositioning approaches take substa...

Descripción completa

Detalles Bibliográficos
Autores principales: Alamgir, Joy, Yajima, Masanao, Ergas, Rosa, Chen, Xinci, Hill, Nicholas, Munir, Naved, Saeed, Mohsan, Gersing, Ken, Haendel, Melissa, Chute, Christopher G, Abid, M. Ruhul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8043466/
https://www.ncbi.nlm.nih.gov/pubmed/33851170
http://dx.doi.org/10.1101/2021.03.22.21254110

Ejemplares similares

Ejemplares similares